These findings suggest that NTN1, DSCAM, and NEO1 are regulated by HDACs in renal cell carcinoma, thus providing new concepts for the use of HDACis in the treatment of renal cell carcinoma. This evidence concerns the gene NEO1 and renal cell carcinoma.